Medical News Today carefully vets every telehealth service that offers GLP-1 medications
This is the step most people rush, and rushing it is the most common cause of leakage or an incomplete dose
Eli Lilly submitted orforglipron to the FDA for approval as an obesity treatment in 2025
As studies continue, researchers say the medications are increasingly being examined not only as metabolic treatments, but also as drugs that may influence brain function, behavior and emotional regulation
[DOI] [PMC free article] [PubMed] [Google Scholar] 26.Wongsaroj L., Saninjuk K., Romsang A., Duang-Nkern J., Trinachartvanit W., Vattanaviboon P., Mongkolsuk S
Chronic Disease Management: Impaired cognition hinders an individuals ability to manage chronic diseases like diabetes or cardiovascular conditions, leading to complications and reduced lifespan